Agilent LC system targets biologically active substances
Liquid chromatography is being used to characterise biologically active substances

Bioanalytical

Agilent LC system targets biologically active substances

21 Jun, 2010

Published over 16 years ago. See the latest and most current information on Bioanalytical.

Biologically active substances can be identified and characterised using a liquid chromatography (LC) system developed by Agilent Technologies.

The company's newly launched 1260 Infinity bio-inert quaternary LC system offers the highest resolution per time of any current bio-inert bioseparation method based around LC, the firm says.

By combining a 600-bar power range with a standard detector, it also promises low limits on detection.

Agilent LC marketing director Stefan Schuette says: "This new system is a complete solution for addressing the growing demand to analyse new biological entities and biosimilars."

This need arises from drug developers' desire to demonstrate the efficacy and safety of biologically active substances, he adds.

A key element in improving the design over previous similar LC systems is the elimination of iron and steel from the solvent delivery process.

This, Agilent explains, means there are fewer surface interactions when analysing biomolecules, as well as extending column lifespan.

Latest News

Explore Our Other Sites

Labmate Online
Mayo Clinic and Thermo Fisher Scientific launch Precure LLC to identify signs of disease before their symptoms appear
Explore more Arrow
Envirotech Online
Connected safety technology company announces CEO appointment and leadership transition
Explore more Arrow
Pollution Solutions Online
Smarter wastewater management helps futureproof distillery operations and protect local watercourses
Explore more Arrow
Petro Online
Improving repeatability in diesel fuel lubricity testing
Explore more Arrow